Login / Signup

Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer.

Kim N ChiDana RathkopfMatthew R SmithEleni EfstathiouGerhardt AttardDavid OlmosJi Youl LeeEric J SmallAndrea Juliana Pereira de Santana GomesGuilhem RoubaudMarniza SaadBogdan ZurawskiValerii SakaloGary E MasonPeter FrancisGeorge WangDaphne WuBrooke DiorioAngela Lopez-GitlitzShahneen Sandhunull null
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Combination treatment with niraparib + AAP significantly lengthened rPFS in patients with HRR+ mCRPC compared with standard-of-care AAP.
Keyphrases
  • healthcare
  • squamous cell carcinoma
  • small cell lung cancer
  • palliative care
  • quality improvement
  • pain management
  • chronic pain
  • replacement therapy